Show simple item record

dc.contributor.authorBromley, Hannah Louise
dc.date.accessioned2020-01-13T03:15:20Z
dc.date.available2020-01-13T03:15:20Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/11343/233805
dc.descriptionCompleted under a Cotutelle arrangement between the University of Melbourne and University of Birmingham
dc.description© 2019 Hannah Louise Bromley
dc.description.abstractMammography screening is deemed cost-effective for women aged 50-70. Yet the utilities informing breast screening policy are limited in their ability to adequately capture the benefits and risks. The evaluation of many cancer screening programmes present results in terms of cost per QALY but fail to include any disutility for the patients who have been over-diagnosed and may receive unnecessary treatment. This thesis presents an overview of the challenges associated with valuing breast cancer states, using the results of an empirical study deriving utilities from 172 women in Melbourne, Australia as an example of potential methods to capture the disutility of overtreatment. Ductal carcinoma in situ was used as a proxy to quantify the benefits and harms associated with the sequelae of screening. Utilities derived from 172 women for health states explicitly describing overdiagnosis were lower than those from the literature, where it is unlikely that women were informed that their treatment may have been unnecessary. Qualitative interviews of 26 patients validated that this risk was important in the valuation of treatment. The findings were used to inform an economic model which demonstrated that the explicit inclusion of the harms of screening may change the decision on breast screening strategy.
dc.rightsTerms and Conditions: Copyright in works deposited in Minerva Access is retained by the copyright owner. The work may not be altered without permission from the copyright owner. Readers may only download, print and save electronic copies of whole works for their own personal non-commercial use. Any use that exceeds these limits requires permission from the copyright owner. Attribution is essential when quoting or paraphrasing from these works.
dc.subjectBreast cancer
dc.subjectScreening
dc.subjectDuctal carcinoma in situ
dc.subjectHealth economics
dc.subjectHealth state valuation
dc.titleQuantifying the benefits and harms of treating ductal carcinoma in situ for use in the economic evaluation of breast cancer screening programmes
dc.typePhD thesis
melbourne.affiliation.departmentMelbourne School of Population and Global Health
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.thesis.supervisornameCarolyn Nickson
melbourne.contributor.authorBromley, Hannah Louise
melbourne.thesis.supervisorothernameDennis Petrie
melbourne.thesis.supervisorothernameGregory Mann
melbourne.tes.fieldofresearch1111799 Public Health and Health Services not elsewhere classified
melbourne.tes.fieldofresearch2140208 Health Economics
melbourne.tes.confirmedtrue
melbourne.accessrightsThis item is embargoed and will be available on 2022-01-13.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record